Silk Fibroin Microfluidic Devices for Biodegradable BioMEMS
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing biomedical micro-electro-mechanical systems (BioMEMS) face challenges with non-degradable materials that are not suitable for implantable applications, posing health and safety concerns, and biodegradable materials often have poor mechanical, electrical, and biological properties.
Innovation Solution
The use of silk-based materials, specifically silk fibroin, for fabricating biodegradable microfluidic devices through an aqueous molding process, offering robust mechanical properties, biocompatibility, and controlled biodegradation, allowing for the creation of microdevices with microchannels and cell growth support.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Strength
If traditional non-degradable materials (silicon, PDMS) are used for BioMEMS fabrication, then mechanical strength and structural stability are improved, but biocompatibility and safety for implantable applications deteriorate
Solution Approach 1:
The patent changes the material parameter from non-degradable to biodegradable by using silk fibroin, while maintaining mechanical strength through controlled processing conditions (aqueous molding, specific humidity, temperature control during fabrication). This resolves the contradiction by showing that biodegradable materials can achieve sufficient mechanical properties for implantable applications.
Solution Approach 2:
The patent uses silk fibroin as a composite biomaterial that combines the benefits of natural protein-based degradation with engineered mechanical strength. The material integrates biocompatibility (non-toxic degradation products) with structural integrity through its unique molecular structure and processing methods.
2Object-affected harmful factors
If biodegradable materials (gelatin, alginate, PLA, PLGA, PGS) are used for BioMEMS fabrication, then biocompatibility and safety are improved, but mechanical properties and structural stability deteriorate
Solution Approach 1:
The patent changes the processing parameters by using aqueous molding instead of traditional methods, controlling humidity and temperature during fabrication. This enables silk fibroin to achieve mechanical strength comparable to or exceeding traditional biodegradable materials while maintaining full biodegradability and biocompatibility.
Solution Approach 2:
The patent uses soft lithography to create precise microchannel structures in silk films, copying the successful microfabrication approaches from PDMS while adapting them to work with biodegradable silk materials. This transfers the structural precision benefits to biocompatible materials.
3Object-affected harmful factors
If silk fibroin is used for microfluidic device fabrication, then full biodegradability and biocompatibility are improved, but manufacturing complexity increases
Solution Approach 1:
The patent divides the device into separate silk films that are individually fabricated using aqueous molding, then assembled together. This segmentation allows for simpler individual film fabrication while achieving the final complex microfluidic structure through modular assembly, reducing overall manufacturing complexity.
Solution Approach 2:
The patent uses aqueous solutions as intermediaries in the fabrication process, allowing silk fibroin to be processed in water-based environments that are easier to handle than organic solvents. The aqueous molding process uses water as a mediator to achieve film formation and bonding without complex chemical processing.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Silk-based microfluidic devices are fully biodegradable, exhibit robust mechanical properties, and support cell growth, addressing the limitations of traditional materials by providing a safe and effective solution for in vivo applications such as drug delivery and tissue engineering.
Implementation Method 1
The silk solution is cast onto a mold and dried to form a solid silk film
Implementation Method 2
The two silk films are bonded together by heat and pressure to form an enclosed microchannel structure
Data Source
AI summary
A microfluidic device includes, in one embodiment, a first silk film coupled to a second silk film with at least one microchannel therebetween.